Choreo LLC’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$658K Buy
36,645
+5,789
+19% +$81K 0.01% 841
2026
Q1
$291K Buy
30,856
+3,294
+12% +$36.2K ﹤0.01% 1273
2025
Q4
$349K Sell
27,562
-2,299
-8% -$30.6K ﹤0.01% 1122
2025
Q3
$428K Buy
+29,861
New +$409K 0.01% 1006
2025
Q2
Sell
-21,654
Closed -$476K 1561
2025
Q1
$476K Sell
21,654
-620
-3% -$14.6K 0.01% 859
2024
Q4
$500K Buy
22,274
+5,123
+30% +$112K 0.01% 909
2024
Q3
$300K Buy
17,151
+5,536
+48% +$128K ﹤0.01% 1203
2024
Q2
$336K Buy
+11,615
New +$344K 0.01% 1032

Other funds holding IART

Choreo LLC's IART Position: Q2 2026 in Review

Choreo LLC increased its Integra LifeSciences (IART) stake by 19% in Q2 2026, buying an estimated $81K and bringing the position to 36,645 shares worth $658K. The position accounts for 0.01% of the portfolio, ranked #841.

Choreo LLC first reported a position in IART in Q2 2024 and has held it in 8 quarters since. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Choreo LLC held 36,645 shares of Integra LifeSciences worth $658K as of Q2 2026.
  • Choreo LLC bought 5,789 Integra LifeSciences shares in Q2 2026, an estimated $81K.
  • Integra LifeSciences made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #841 holding.
  • Choreo LLC first reported a position in Integra LifeSciences in Q2 2024 and has held it in 8 quarters since.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.